Global Congress on Prostate Cancer - PROSCA 2020

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Global Congress on Prostate Cancer - PROSCA 2020

Videos
Event

Playback speed

10 seconds

2020 Updates on mHSPC: DT + RT, ADT + 6 Cycles Docetaxel, or Novel AR-Targeted Agents - What Factors Can Help Us to Choose the Best Option?

By Global Congress on Prostate Cancer - PROSCA 2020 FEATURING Ursula Vogl

125 views

November 26, 2020

Comments 0

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

Feat. R. Alter, A. Rezazadeh

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Videos

2020 Update on MRI in PC: What Are the Guidelines for Delivering a H…

Global Congress on Prostate Cancer - PROSCA 2020

A. Padhani

166 views

2020 Updates on mHSPC: DT + RT, ADT + 6 Cycles Docetaxel, or Novel A…

Global Congress on Prostate Cancer - PROSCA 2020

U. Vogl

125 views

2020 Update on mCRPC: Which Patients Can Benefit From PARPi? Can Pre…

Global Congress on Prostate Cancer - PROSCA 2020

E. Castro

125 views

2020 Update on PSMA-PET in PC: Does It Make a Difference for Patient…

Global Congress on Prostate Cancer - PROSCA 2020

J. Calais

287 views

2020 Update on IO for Advanced PC: Is There an OS Benefit w/ Sipuleu…

Global Congress on Prostate Cancer - PROSCA 2020

P. Grivas

223 views

2020 Update on nmCRPC: Are Apalutamide, Darolutamide & Enzalutamide …

Global Congress on Prostate Cancer - PROSCA 2020

C. Ryan

459 views

2020 Update on MRI in Active Surveillance for PC: What Is the Aim, E…

Global Congress on Prostate Cancer - PROSCA 2020

J. Stranne

133 views

PC Robotic Radical Prostatectomy at Mount Sinai Health: How Does Hoo…

Global Congress on Prostate Cancer - PROSCA 2020

A. Tewari

44 views